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Standardized Method for High-Resolution 1H-NMR of Cerebrospinal Fluid
Ron A. Weyers,1’4 Udo Engelke,1 Udo Wendel,2 Jan G.N. de Jong,1 Fons J.M. Gabreels,1 and Arend Heerschap3
This study describes a standardized method for record­
ing single-pulse 1H-nuclear magnetic resonance (1H- 
NMR) spectra from cerebrospinal fluid (CSF). Quantita­
tive data for alanine, valine, threonine, and lactic acid 
correlated well with data obtained with conventional 
techniques. The pH of the samples is important for the 
reproducibility of the chemical shift of resonances, and 
should be standardized to improve recognition and as­
signment of resonances. A database of resonances from 
various metabolites is presented. Fifty compounds could 
be identified in CSF, 15 of which had not been observed 
earlier in NMR studies of CSF. We describe for the first 
time in the literature, to our knowledge, 3-hydroxyisova- 
leric acid as a regular component of many CSF samples. 
As examples of the diagnostic power of the technique, 
spectra are shown of CSF from patients with three 
different inborn errors of metabolism. We found high 
concentrations of N-acetylaspartic acid, citric acid, and 
succinic acid in CSF from a patient with Canavan dis­
ease. This is Indirect evidence for the existence of a 
carrier mechanism that is shared by these di- and tricar­
boxylic acids.
Indexing Terms: Canavan disease/formic acid/histidinemia/3-hy- 
droxyisovaleric acid/3-methylcrotonyl-CoA carboxylase deficien­
cy/inborn errors of metabolism/dicarboxylic acid transport/(meta­
bolic) screening
In some inherited metabolic diseases, analysis of 
cerebrospinal fluid (CSF) is more suited than other 
body fluids to find an abnormal metabolite concentra­
tion that may lead to a particular diagnosis.5 Nonke­
totic hyperglycinemia may serve as an example for 
which measurement of glycine in CSF is absolutely 
essential for diagnosis (1). Furthermore, derange­
ments of organic acid concentrations in CSF may occur 
independently of the systemic metabolism (2 - 4 ). Thus, 
analysis of metabolites in CSF may be important in the 
diagnosis and follow-up of patients with inherited neu- 
rometabolic disease.
XH-Nuclear magnetic resonance (NMR) spectroscopy 
presents an overview of many ^-containing metabo­
lites in a body fluid sample; therefore, it can be used to 
identify quantitatively many metabolites of interest for 
the study of inborn errors of metabolism. Sample
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pretreatment is simple and no derivatization is re­
quired. Few data on CSF based on 300-600-MHz 
1H-NMR spectrometers have been presented in the 
literature (2, 5 - 8 ). Mainly adult patients with various 
clinical conditions such as diabetes, vascular disease, 
tumors, infectious disease, intoxication, trauma, mul­
tiple sclerosis, Huntington chorea, or neurofibrosis 
have been studied (2, 5-7, 9 ). But no systematic data 
are available on patients with neurometabolic diseases 
or inherited metabolic diseases affecting the nervous 
system. We have developed a standardized and sensi­
tive assay for this purpose, making use of a 600-MHz 
spectrometer.
Patients and Methods
Sample Pretreatment
CSF samples were centrifuged for cell separation 
(650g, 5 min) within 1 h after lumbar puncture and stored 
at — 80°C until analysis. Samples contained normal 
amounts of bilirubin and hemoglobin. For deproteiniza- 
tion, samples were centrifuged (3000g, 2 h) over a filter 
(Microsep no. ODOXOC45, membrane type omega, molec­
ular mass cutoff 10 kDa; Filtron, Northborough, MA). 
The protein concentration in normal CSF is rather low 
(<0.5 g/L). Although the presence of protein introduces 
broad resonances in a limited range (0.8-1.0 ppm), its 
interaction with the internal standard trimethylsilyl- 
2,2,3,3-tetradeuteropropionic acid (TSP) may adversely 
affect quantification (10,11). Therefore, all samples were 
deproteinized.
To avoid contamination of the ultrafiltrate with 
glycerol, we cleaned the filters by passing 6 mL of 0.05 
mol/L NaOH and 6 mL of distilled water through them 
before use. The sample (2 mL) was passed through this 
filter and the ultrafiltrate was subsequently evapo­
rated in an automatic concentrator (AS290 automatic 
Speed vac concentrator; Savant Instruments, Farming- 
dale, NY). After reconstituting the remainder in 0.5 mL 
of H20, we carefully adjusted the pH to 2.50 ± 0.10 
(glass electrode/room temperature) and again removed 
the solvent with the automatic concentrator. The sam­
ple was redissolved in freshly prepared DaO (0.5 mL) 
with TSP (sodium salt; Merck, Darmstadt, Germany) 
as a chemical shift reference calibrator, to a final 
concentration of 0.812 mmol/L TSP. Routinely, we 
concentrated samples fourfold. However, depending on 
the available sample volume, the concentration factor 
was varied between 1 and 4 in this study.
NMR Measurements
XH-NMR spectra (600 MHz) were obtained on a 
Bruker AMX-600 (Bruker Analytische Messtechnik,
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Karlsruhe, Germany) spectrometer at 298°Kby using a 
60° radio frequency pulse and a 12-s pulse repetition 
time with 132 averages. The carrier frequency was set 
at the residual H20 resonance. Sample volume in the 
NMR spectrometer was standardized at 400 /¿L. Shim­
ming of the sample was judged to be adequate when the 
29S i-1H long-range coupling of 3 Hz in the TSP reso­
nance could be resolved. The average full width at 
half-maximum peak height for the TSP resonance is 
0.71 Hz (range in 15 samples: 0.48-1.03). The result of 
the shimming of CSF samples was such that the 1.3-Hz 
J-coupling of the j3C2-glucose resonance at 3.23 ppm 
could be observed. The resonance of residual H20 was 
suppressed by low-power continuous-wave presatura­
tion during the relaxation delay. For evaluation of the 
NMR spectrum we used NMR-1 software (version 1, 
release 4; New Methods Research, East Syracuse, NY). 
Chemical shifts were calibrated with respect to the 
chemical shift position of the TSP resonance. The free 
induction decay (FID) was recorded in 16 K datapoints 
with a sweep width of 6605 Hz. FIDs were Fourier- 
transformed after zero filling to 32 K. No digital filter­
ing was applied to the FID. The phase was manually 
corrected, and resonances in the spectra were semiau- 
tomatically fitted to a Lorentzian lineshape model 
function in the frequency domain. No baseline correc­
tion was used. Resonances were assigned by compari­
son with our model compound database containing 200 
compounds (U. Engelke, unpublished results). In a few 
cases a standard addition of a compound could further 
confirm the assignment. Quantitative data in this 
paper were obtained by calculating metabolite concen­
trations from the area of its corresponding resonance(s) 
with respect to the area of the TSP resonance.
Measurements to estimate Tx values were performed 
with an inversion recovery sequence. The delay, after 
the 180° pulse, varied between 0.1 s and 12.8 s. The 
acquisition time was 12.8 s. Data points were fitted to 
a single exponential.
Determination of Amino Acids, Lactic Acid, and 
Organic Acids
Amino acid analysis in CSF was carried out accord­
ing to Gerrits et al. [o-phthaldialdehyde detection (12)]. 
L-Lactic acid in CSF was determined enzymatically 
with a centrifugal analyzer (Cobas-Fara; Hoffmann-La 
Roche, Basel, Switzerland). Organic acids analysis of 
CSF and urine was carried out after ethyl acetate 
extraction and trimethylsilylation with gas chromatog­
raphy-mass spectrometry (GC-MS) on a VG Trio-2 
with a capillary Sil8CB column.
Patients
This study contains data on 40 CSF samples from 29 
children (20 boys, 9 girls) and 11 adults (6 men, 5 
women) clinically suspected to have inherited neuro- 
metabolic diseases. In many cases the disease occurred 
in members of the same family. CSF was obtained for 
diagnostic purposes with parental consent or with 
consent of the patient. Appropriate studies ruled out
immunologic and chronic infectious diseases and disor­
ders caused by toxic agents. The CSF samples in this 
study were left over from clinical work, We present 
data on three patients with the following known inborn 
errors of metabolism: (a) isolated 3-methylcrotonyl- 
CoA carboxylase deficiency (McKusick 210200) (13); (b) 
Canavan disease (Canavan spongiform leukodystro­
phy, aspartoacylase deficiency; McKusick 271900) (13)\ 
and (c) histidinemia (McKusick 235800) (13).
The diagnosis in these patients was established on 
the basis of clinical features and biochemically by 
GC-MS (cases a and b) and amino acid analysis in blood 
and urine (case c). Further confirmation was obtained 
by enzymatic analysis in fibroblasts (cases a and 6).
Results
Tn Measurements
The delay between excitation pulses should be long 
enough to allow sufficient relaxation. Therefore, we 
estimated Tx-values on a CSF sample under the condi­
tions used in this study (fourfold concentration, D20). 
The median Tr value was 1.8 s (range 1-5 s) for 
resonances of 11 metabolites (citric acid 2.91 ppm, 
threonine 1.33 ppm, glutamine 2.47 ppm, alanine 1.51 
ppm, myo-inositol 3.27 ppm, lactic acid 1.41 ppm, 
creatine 3.05 ppm, creatinine 3.13 ppm, glucose 5.22 
ppm, TSP 0 ppm, acetic acid 2.08 ppm). For the TSP 
methyl-group proton spins the T:-value was 3,6 s. On 
the basis of these results we chose a 12-s repetition 
time at a pulse angle of 60°. This resulted in <6% 
saturation for all proton resonances in the spectrum. 
The saturation for the internal standard TSP was 
<2%. This is an important prerequisite for direct 
quantitative analysis of metabolites from the spec­
trum.
CSF 1H-NMR Spectrum
Figure 1 shows the NMR spectrum of a 3.2-fold­
concentrated normal CSF sample. Resonances in the 
CSF spectra are further explained in Table 1, which 
mentions all resonances that could be assigned even 
when they occurred only in one CSF sample, A total of 
50 compounds could be identified in the CSF samples.
The chemical shift of the resonances is very repro­
ducible. The standard deviations in the chemical shift 
of citric acid (2.91 ppm AB), alanine (1.51 ppm doublet), 
creatine (3.05 ppm singlet), lactic acid (1.41 ppm dou­
blet), and histidine (8.68 ppm doublet) were 0.013, 
0.011, 0.005, 0.003, and 0,003 ppm, respectively, in 28 
CSF samples. To establish the influence of pH, we 
measured a CSF sample at different pD values (Table
2). The actual pD value of the sample was measured 
after evaporation and reuptake in D20. The variations 
in chemical shift vary considerably per metabolite. 
Within one molecule the sensitivity of two resonances 
may vary. The quartet resonance of lactic acid arising 
from its a-proton, for instance, is more sensitive for pD 
changes than the lactic acid doublet arising from the 
methyl-group protons (data not shown).
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Fig. 1. 600-MHz 1H NMR spectrum of a representative normal CSF sample.
New Assignments of Resonances in CSF
Using conventional techniques, Gerrits et al. (12), 
Hoffmann et al. (3), and Kusmierz et al. (14) have
leric acid, 2-oxoisovaleric acid, [13C]lactic acid, 2-hy- 
droxyisobutyric acid, ascorbic acid (vitamin C), 1,5- 
anhydrosorbitol, fructose, and mannose. The presence
reported on the occurrence in CSF of amino acids, of the compounds contributing to these resonances was
organic acids, and polyols, respectively. Reiber et al. confirmed by GC-MS. Where possible, both the J-
indicated the presence of vitamin C in relatively high coupling of the resonance and addition of the model
concentrations in CSF (15). Taking into account the compound to the CSF samples during the NMR mea-
sensitivity of the NMR technique, we thus obtained surements were used to confirm the identity of the
several candidates for unassigned resonances. This compound. Quantitative NMR data on these metabo-
resulted in resonance assignments for 2-hydroxyisova- lites were in the same ranges as described elsewhere
Table 1 .1H-NMR resonances from metabolites observed in 40 CSF samples.
Metabolite
TSP
%• Chemical shift and multiplicity [proton(s)]b
0.00 s [Si-(CH3)3]
2-Hydroxyisovaleric acid° 58 0.89 d [CH3]; 0.98 d [CH3]; 4.13 d [CH]
Isoleucine0 73 0.94 t ICHa]; 1.02 d [CHa]
Leucine0 100 0.95 d [CHg]; 0.97 d [CH^
Valine0 93 1.00 d [CH3 ]; 1.04 d [CHa]
 ^d 65 1.08 t (J-coupling = 7.1 Hz)
x2 25 1.11 d (J-coupling = 6.6 Hz)
1,2-Propanediol® 15 1.13 d [CH3] (J-coupling = 6.4 Hz); 3.48 AB [CH2]
2-Oxoisovaleric acid° 83 1.13 d [(CH3)2] (J-coupling = 7.1 Hz)
x3 2.5 1.17s
x4
8 % occurrence in 40 samples.
40 1.17 t (J-coupling = 6.2 Hz)
b  s, singlet; d, doublet; dd, doublet/doublet; t, triplet; q, quartet; m, multlplet; and AB, AB-system (second-order coupling). 
c Only the most important signals are shown.
d x1, x2, etc., resonances from unknown metabolites.
8 Medication-derived,
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Table 1. Continued.
Metabolite %*•
x5 2.5 1.19
S.e-Dihydrothymine® 2.5 1.19
3-Hydroxybutyric acldc 85
*  •  9
1.23
11:4C] Lactic acid 100 1.30
3-Hydroxyisovalerlc acid 70 1.33
Threonine® 100 1.33
Lactic acid 100 1.41
2-Hydroxyisobutyrlc acid 8 1.44
x8 13 1.46
Alanine 100 1.51
X? 58 1.56
x8 10 1.58
Lysine®' 70 1.72
4-Hydroxy butyric acid 2.5 1.83
Thymine* 2.5 1.86
N Acatyltyrosine 2.5 1.94
x9 58 1.99
x10 45 2.02
Af-Acetylaspartic acid 2.5 2.03
x11 43 2.04
W-Acetyineuraminic acid 85 2.05
x12 75 2.07
Acetic acid 100 2.08
Methionine® 2.5 2.13
Glutamine 100 2.16
Acetone ? 2.22
Acetoacetic acide 58 2.31
Pyruvic acid 75 2.37
4-Hydroxybutyric acid lactone 2.5 2.58
x13 2.5 2.61
Succinic acid 13 2.67
5,8“Oihydf’ouracile 2.5 2.68
Sarcoslne 2.5 2.74
Citric icid 100 2.91
Creatine 100 3.05
Creatinine 100 3.13
x14 88 3.14
Choline 50 3.19
Carnitine 2.5 3.22
Glucose® 100 3.23
aC,]
myo-lnositoF 100 3.27
Bfitain© ? 3.27
1,5“AnhydrosorbitoP ? 3.34
xlS 2.5 3.35
frucW SQ * ? 3.56
Glycine ? 3.72
Serf nit 49 3.98
Glycolic acid 62 4.18
Ascorbic acid (vitamin Of 50 4.97
Mannose® 33 5.17
x16 55 5.42
Uracil6 2.5 5.79
T yrosine4' 70 6.89
Phenylalanine® 45 7.32
Formic acid 40 8.25
Histidine4* 48 8.68
Chemical shift and multiplicity [proton(s)]b
 d [CH3]; 2.53 AB [CH2]
 s [(CH3)2]; 2.55 s [CHJ
 d [CH3]; 4.36 q [CH]
 d (J-coupling = 7.1 Hz)
 m [CH2]; 1.92 m [CH2]; 3.01 t [CHa] 
.  m [CHd; 2.44 t [CH2]; 3.62 t [CHg]
C-CH3]; 6.85 d [aromatic]; 7.16 d [aromatic]
C-CHg]; 2.95 AB
C-CH3] (tentative)
 s [CH3]; 2.67 t [CH]
 m [CH2]; 2.47 m [CHJ; 3.91 t [CH] 
 s [0=C-(CH3)o] (volatile)
 t [CH2]; 4.441 [CH2] (tentative) 
t (J-coupling = 6.6 Hz)
 s [N-CHg]; 3.65 s [CH2]
 s [N-CHg]; 4.06 s [N-CHJ 
 s [N-CHg]; 4.29 s [N-CH2]
 dd [CH: J3C2]; 3.3-3.9 (various); 4.64 d [CH: J3C,]; 5.22 d [CH:
. 71 [CH: C-5]; 4.05 t [CH: C-2]
 s [N-(CH3)3]; 3.94 s [CH2]
 m [ring proton]; 3.271 [ring proton]
61 [ring proton]
 d [ring proton]
5.5 Hz)
 d [aromatic protons]; 7.19 d [aromatic protons] 
 m [aromatic protons]
 s (tentative/volatile)
 d [ring proton]; 7.41 s [ring proton]; 4.09 t [CH2]
occurrence
k  8( singlet: d, doublet; dd, doublet/doublet; t, triplet; q, quartet; m, multiplet; and AB, AB-system (second-order coupling).
Only the most Important signals are shown.
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(3,12,14,15). From our studies on patients with inher­
ited metabolic disease we were able to make seven new
Quantitative Analysis by NMR vs Conventional Techniques 
The methyl-group doublet resonance of alanine, va-
assignments, which were confirmed by GC-MS analysis Hne, threonine, and lactic acid was used for correlation
of the samples: sarcosine, 5,6-dihydrothymine, 5,6-dihy- studies with conventional techniques (x) (Table 3).
drouracil, AT-acetyltyrosine, 3-hydroxyisovaleric acid, and Passing and Bablok regression analysis (17) showed a 
4-hydroxybutyric acid and its lactone. 3-Hydroxyisova- good correlation for all four metabolites: The slopes and 
leric acid occurs in a high percentage of the CSF samples intercepts of the regression lines did not differ signifi-
that we measured (Table 1).
Unknown Resonances 
Table 1 describes 16 unknown resonances occurring
cantly from one and zero, respectively. The regression 
lines found were: for lactic acid, y  = l.Olx + 0.18 (95% 
confidence intervals in,y = ax + b: a, 0.99-1.33; b, -0.4  
to 0.2); for alanine, y  = 0.96a; + 0.65 (95% confidence
in one or more CSF samples. Unknown resonances intervals: a, 0.71-1.18; b, 7.3 to 7.5); for threonine, y
were included if their signal/noise ratio was >3. As 
shown in our earlier study (16), some of the unknowns 
occur occasionally in plasma samples (singlets: 1.56, 
1.58, 3.14, 8.25 ppm; doublet: 1.11 ppm); others do not 
(singlets: 1.99, 2.02, 2.07 ppm; doublet: 5.42 ppm; 
triplet: 1.08 ppm). The triplet resonance at 1.17 ppm
b,
0.97# + 1.17 (95% confidence intervals: a, 0.72-1.14;
6.2 to 10.2); for valine, y 1.06x 1.21 (95%
confidence intervals: a, 0.83-2.33; b, —25 to 4),
Sensitivity and Detection Limit 
We estimated the detection limit for the methyl-
was observed in 40% of the CSF samples but in only 8% group doublet of threonine as 10 ^mol/L on the 600-
of the plasma samples (16). From four patients that MHz spectrometer, assuming a signal/noise ratio >3.
had this resonance in CSF we measured a plasma The sensitivity of the technique for other nonvolatile
sample that was obtained within 1 h of the lumbar metabolites depends on the number of equivalent pro­
puncture. The 1.17-ppm triplet was not present in tons that contribute to the resonance and on the
these four plasma samples. Similarly, the 5.42-ppm multiplicity of the resonance. These data, which can be 
doublet resonance was not observed in plasma samples calculated from the detection limit for threonine (16),
in our earlier study (16) but occurred in 55% of our CSF 
samples.
varied for different metabolites between 2 and 40 
/xmol/L (16).
Table 2. Chemical shift (ppm) of various resonances in
CSF at various pD values.
A  ppm at pD
ppm® at 
pD = 2.54 2.24 2.80 9.29
Creatinine 3.133 0 — 0.001 -0.016
Creatine 3.053 0.009 -0.006 -0.011
Lactic acid 1.409 0.003 -0.002 -0.076
Threonine 1.329 0.008 — 0.003 -0.069
Alanine 1.507 0.019 -0.011 -0.071
Citric acid 2.918 0.019 -0.012 -0.285
a Protons as indicated in Table 1,
Volatile Compounds and NMR-invisible Compounds
Because of the evaporation step, volatile components 
can remain unobserved under the conditions described 
here. To study this, we measured CSF samples both in 
D20  and in H20  (without the evaporation step). The 
concentrations of acetone, acetoacetic acid, formic acid, 
and the unassigned triplet at 1.17 ppm were clearly 
influenced by the evaporation step. Other resonances 
were essentially unaffected by this procedure. Of 
course, an exchange of a proton with deuterium as 
described for methylmalonic acid may be another rea­
son why a resonance of a compound becomes invisible 
under the conditions used (16).
m m tm m vn ta
Table 3. NMR quantitative data for CSF samples compared with conventional amino acid analysis* or enzymatic
analysis* results.
Alanine, ¿imol/L Threonine, umol/L Valine, ¿<.mol/L Lactlc acid, mmol/L
m m * * * * * * * * * * * *
Sample NMR Conventional* NMR Conventional* NMR Conventional” NMR Conventional0
1 18 18 30 32 16 14 2.2 1.8
2 42 48 64 73 23 26 2.3 2.1
3 34 35 28 21 14 17 1.7 1.7
4 36 37 22 19 21 21 1.5 1.4
5 20 23 17 20 21 20 nd nd
6 16 14 33 30 24 20 1.5 1.3
7 32 30 28 23 21 20 nd nd
8 230 201 255 258 202 205 20.3 20.0
9 31 35 29 33 16 16 1.5 1.3
10 23 22 41 36 30 24 1.1 1.0
11 19 24 14 18 14 18 1.9 1.7
12 31 23 43 47 16 18 2.3 2.0
nd, not determined.
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Inherited Metabolic Disease A major advantage of NMR spectroscopy is the over-
As examples of the diagnostic power of the technique, all view of the metabolic profile of the body fluid under
g. 2 shows relevant parts of spectra from CSF samples study. This may lead to unexpected findings, as illus-
patients with isolated 3-methylcrotonyl-CoA carboxy- trated by the example of the patient with Canavan
se deficiency, Canavan disease, and histidinemia. disease. Apart from A -^acetylaspartic acid, which was
Fig. 2A. In the CSF of our patient, 3-methylcrotonyl- >50-fold increased, both citric acid and succinic acid in
a  I  .*4  *  M  _________
iQuDiei resonances at l.bb and 2.03 ppm {11 
demonstrated with neither XH-NMR spectn 
GC-MS. It could, however, be demonstrated
CSF were increased about fourfold. Our reference 
range for citric acid in CSF (mean 243 /xmol/L, range 
105-625 /xmol/L) is in agreement with NMR data by
the patient's urine by both methods. 3-Hydroxyisova- Bell et al. (6) and GC-MS data by Hoffmann et al. (3), 
leric acid was observed in the patient’s CSF at 540 but is significantly higher than the reference range
/xmol/L (reference mean: 5 /xmol/L
/xmol/L)
recognized by
(Fig/ 2A, Tal 1), With MS
/xmol/L
reported by Duran et al. [GC-MS: <100 /xmol/L (20)]. 
Succinic acid can hardly be detected by 1H-NMR spec­
troscopy in normal CSF, which is in agreement with 
the low reference values found for this compound in the 
literature [<5 /xmol/L (3 )]. Our observations are in part
centrations of lactic acid and tiglylglycine in urine and confirmed by Burlina et al. (21), who found 42 /xmol/L
deficiency
excluding multiple carboxylase succinic acid in CSF of a patient with Canavan disease.
synthase
tf. 2B. 2\T-Acetylaspartic
/xmol/L
more
Their study does not mention citric acid. Furthermore, 
the NMR spectrum of a urine from a patient with 
Canavan disease presented by Grodd et al. (22) seemed 
to contain no citric acid, in contrast to the control 
sample. In 200 urine samples we have always found
creased in this sample [citric acid 2398 /xmol/L, detectable quantities of citric acid. Succinic acid and 
reference range 105-625 (n = 33); succinic acid 19 2V-acetylaspartic acid are dicarboxylic acids, and citric
/xmol/L /xmol/L 33)1. Other acid is a tricarboxylic acid. Dicarboxylic acids are
di- or tricarboxylic acids were not observed in the known not to be transported by the organic acid carrier
sample system in the choroid plexus (23). Our observation
2C. Histidine can be recognized by its 8.69-ppm suggests that removal of these di- and tricarboxylic 
doublet, due to a long-range coupling (J-coupling, 1.3 acids from CSF shares a common path, perhaps a 
Hz). Nearly identical values were found for the CSF specific carrier. Competition for such a carrier would
histidine concentration in histidinemia by NMR
ammo
umol/L (reference range <30 /xmol/L)j
Discussion
Federico et al. (19) used NMR spectroscopy to dem
nicely explain the high values of the di- and tricarbox­
ylic acids in CSF and the low citric acid value in urine. 
Our observation in Canavan disease awaits confirma­
tion in other patients.
Recently the state of the art for organic acid analysis 
with GC-MS in CSF was described by Hoffmann et al.
onstrate a mitochondrial encephaloneuromyopathy in (3 ). Although they do not mention the occurrence of
To our knowledge, no further studies have 3-hydroxyisovaleric acid in CSF, we observed this com­
pound in 76% of the CSF samples. Lehnert and
Hunkier (18) were the first to describe the NMR
a
used this diagnosing
metabolism in CSF. Our data show that the technique 
can be used as such; From the spectra obtained we resonances of this compound, which seems to be a
«H - , i  / S i  “ |  *  * 1  *  ♦  1  •
were to identify and quantify relevant metabolites normal constituent of CSF. 3-Hydroxyisovaleric acid is
in CSF from patients with three separate inborn errors not commercially available as a model compound,
which may be why this compound was not mentioned
aeltf
1
3-Hydroxyisovaleric acid
4
■a*
ï I M: L
.1 I *
ppm a.to
Fig. 2. BOO-MHz
(C) histidinemia.
2,10 1.80
A, A * a
Citric acid
Lucila odd
I
N-Acetyiaspartic acid
Succinic
acid
Histidine
-CoA carboxylase deficiency; (S) Canavan disease;
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in the Hoffmann paper (3). Alternatively, steric hin­
drance of the methyl groups may influence the effi­
ciency of the derivatization in the GC-MS technique. 
This would also explain the discrepancy between the 
quantitative data for this compound by NMR and 
GC-MS in the patient with isolated 3-methylcrotonyl- 
CoA carboxylase deficiency (NMR 540 vs GC-MS 15
/xmol/L). For three reasons we are confident that the 
resonances observed in the NMR spectrum were really 
caused by 3-hydroxyisovaleric acid:
1) The chemical shift of the two singlet resonances in
the NMR spectrum of this patient’s CSF at 1.33 and 
2.55 ppm corresponded exactly with the values found 
by Lehnert and Hunkier (18) for 3-hydroxyisovaleric 
acid in urine.
2) The two resonances had the expected area ratio 
for 3-hydroxyisovaleric acid.
3) The diagnosis in our patient was confirmed by 
enzymatic analysis so there remained no doubt about 
the diagnosis. GC-MS studies have well established 
that 3-hydroxyisovaleric acid is the major abnormal 
metabolite in CSF in this disease (20).
Reliable quantification of 3-hydroxyisovaleric acid 
might be relevant, given suggestions that it may have 
a specifically harmful effect on the brain (20). 3-Hy- 
droxyisovaleric acid may also be present in plasma, but 
there the 1.33-ppm singlet resonance is obscured by the 
threonine doublet. Because the concentration of threo­
nine in plasma is much higher than in CSF, the two 
compounds cannot be separated in plasma under the 
conditions used in our study (16).
Volatile organic acids such as acetic acid and formic 
acid will escape detection because of the evaporation 
step necessary to replace H20  by D20. Still, the char­
acteristic acetic acid resonance was present in many of 
the samples, perhaps through contamination of the 
samples by acetic acid present in disposable pipette 
tips (10). This may also have interfered in the NMR 
study of Commodari et al., which gives a reference 
range for acetic acid between 0.05 and 4.5 mmol/L (2). 
In several samples (40%) we found a singlet resonance 
at 8.25 ppm, the resonance position of formic acid (Fig. 
2C). Formic acid in CSF was described in the NMR 
studies of Bell et al. (6) and Sweatman et al. (8). One of 
our CSF samples was measured both with and without 
the evaporation step. The peak area of the 8.25-ppm 
singlet clearly diminished upon evaporation (47 vs 9 
jumol/L). It cannot be excluded that an as-yet-uniden- 
tified compound has the same chemical shift. Obvi­
ously, formic acid cannot be measured quantitatively 
under the conditions in this study. Its presence in 
rather high concentrations in CSF awaits confirmation 
with other techniques. The observation may be of 
interest, as Poulos et al. recently described formic acid 
as a product of a-oxidation of fatty acids (24).
Several sugars and polyols are known to occur in CSF 
in rather high concentrations (14), e.g., mannose, fruc­
tose, sorbitol, and 1,5-anhydroglucitol. These compounds 
were not reported in earlier NMR studies of CSF. Detec­
tion of these compounds is complicated by the presence of
the many high resonances of glucose that obscure the 
spectral region between 3.30 and 3.95 ppm. Under the 
conditions used in our study we were not able to detect 
sorbitol, but mannose, fructose, and 1,5-anhydroglucitol 
could be demonstrated in the spectra. A reliable percent­
age of occurrence cannot be given for the latter two, 
however, because of overlapping glucose resonances in 
many of the samples. We observed the mannose doublet 
with its characteristic 1.85-Hz J-coupling in 33% of the 
CSF samples. The highest concentration seen was 35 
/xmol/L.
We found 16 as-yet-unassigned resonances in the 
CSF. Some of these may be caused by the medication 
given to the patient; however, because many of these 
unknowns occur in a high percentage of the samples, 
this explanation does not seem very likely. Some un­
knowns were also found in plasma samples (16) and 
may have reached the CSF from the blood (singlets: 
1.56, 1.58, 3.14, 8.25 ppm; doublet: 1.11 ppm). The
doublet resonance at 5.42 ppm and the triplet reso­
nances at 1.08 and 1.17 ppm were seen in 40-65% of
«1« i l k
the CSF samples. The former two were not observed in 
plasma samples and the 1.17 triplet was found in only 
8% of the plasma samples (16). Four patients that had 
this triplet in CSF did not have it in measurable 
concentration in a simultaneous plasma sample. These 
three resonances (1.08,1.17, and 5.42) seem specific for 
CSF and may originate from the brain.
For some unknowns there are likely candidates: The 
sugar acids 2,4-dihydroxybutyric acid and 3,4-dihy- 
droxybutyric acid occur in concentrations that should 
be detected by our technique (3). However, these com­
pounds are not commercially available as model com­
pounds , and we have not been able to identify them in 
the spectra. Two-dimensional NMR spectroscopy 
(COSY) may help to find the resonances from these 
sugar acids. Furthermore, the unknown singlets at 
1.99, 2.02, 2,04, 2.05, and 2.07 ppm may derive from 
N-acetyl groups in various metabolites. As a model 
compound, N-acetylneuraminic acid, for instance, 
causes a singlet at 2.05 ppm. Definite assignment of 
the 2.05-ppm singlet in CSF samples would require a 
quantitative correlation analysis with an independent 
technique.
Table 1 can be used as a model compound database 
for CSF. Because the relevant conditions in this study 
equal those of Lehnert and Hunkier (18) and of our 
earlier study on plasma (16), an important reference 
set of assigned and unassigned resonances can be 
developed. This model compound database may be used 
in future studies and, we expect, may also be applicable 
to cases of other body fluids or cellular extracts. In our 
experience, these data can be reproduced by others, 
thus providing a powerful tool for metabolic work.
Unlike plasma, CSF has a poor buffering capacity. 
Upon standing, 0 2 and C02 equilibrate with the air, 
and within hours the pH of the sample steadily in­
creases to values of 7.8 and higher (25). Sweatman et 
al. have observed small but consistent chemical shift 
differences after freeze-drying and reconstitution (8).
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These authors explain this by assuming a change in JK, Lindon JC. 600 MHz XH-NMR spectroscopy of human cere-
binding of metabolites to CSF proteins, but they do not 
standardize pH in their study. It is our experience that 
freeze-drying with reconstitution in H20  can alter the
brospinal fluid: effect of sample manipulation and assignment of 
resonances. J Pharmaceut Biomed Anal 1993;11,8:651-64.
9. Koschorek P, Gremmel H, Stelten J, OfFermann W, Leibfritz 
D. Cerebrospinal fluid: detection of tumors and disk herniations
pH to 9.3! Even changes of 0.3 pH units can give with MR spectroscopy. Neuroradiology 1988;167:813-6.
significant and reproducible changes in the chemical 
shift of metabolites (Table 2). Similar significant 
changes of the chemical shift with pH have been 
described by Bales et al. (26). Therefore, the pH should 
be standardized for 1H-NMR measurements in CSF to 
improve the recognition and assignment of resonances.
Another important technical aspect is the relaxation 
delay between two radiofrequency pulses that is re­
quired to enable direct spectral quantification. The 
length of this relaxation delay is dictated by the Tj 
relaxation time of metabolite spin systems. A disad­
vantage of measuring in D20  is that the required Hopkins Press, 1994:2865-3009. 
relaxation interval is longer than that in HaO. From 14- Kusmierz J, DeGeorge JJ, Sweeney D, May C, Rapoport SI.
our Tx measurements on various metabolites we con-
10. Bell JD, Brown JCC, Sadler PJ. NMR studies in body fluids. 
Nucl Magn Reson Biomed 1989;2:246-56.
11. Kriat M, Confort-Gouny S, Vion-Dury J, Sciaky M, Viout P, 
Cozzone PJ. Quantitation of metabolites in human blood serum 
by proton magnetic resonance spectroscopy, A comparative study 
of the use of formate and TSP as concentration standards. NMR 
Biomed 1992;5:179-84.
12. Gerrits GP, Trijbels FJ, Monnens LA, Gabreels FJ, De Abreu 
RA, Theewes AG, van Raay-Selten B. Reference values for amino 
acids in cerebrospinal fluid determined using ion-exchange chro­
matography with fluorimetrie detection. Clin Chim Acta 1989; 
182:271-80.
13. McKusick VA. Mendelian inheritance in man. A catalog of 
human genes and genetic disorders, 11th ed. London: John
eluded that delays of 12 s are necessary to obtain
Quantitative analysis of polyols in human plasma and cerebro­
spinal fluid. J Chromatogr 1989;497:39-48.
15. Reiber H, Ruff M, Uhr M. Ascorbate concentration in human
reliable quantitative data. Our data for Tj values for cerebrospinal fluid (CSF) and serum. Intrathecal accumulation 
several metabolites in CSF agree with data by Commo- an(I CSF flow rate. Clin Chim Acta 1993;217:163-73.
16. Wevers RA, Engelke U, Heerschap A. High-resolution 1H-dari et al. (2). The relaxation delay used in some 
studies on CSF (2.7-6 s) seems inadequately short for 
quantification purposes (8).
NMR spectroscopy of blood plasma for metabolic studies. Clin 
Chem 1994;40:1245-50.
17. Passing H, Bablok W. A new biometrical procedure for 
testing the equality of measurements from two different analyt-
1H-NMR spectra were recorded at the Dutch hf-NMR facility ical methods. J Clin Chem Clin Biochem 1983;21:709-20.
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